Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents
With a long-standing interest in peptide therapy, internal medicine specialist Dr
In the SURMOUNT-1 Phase 3 trial (N=2,539), Tirzepatide at 15mg produced 22.5% mean weight reduction over 72 weeks compared to 2.4% for placebo
Citation10,Citation44,Citation45 The GSSG is highly toxic since it easily reacts with free sulfhydryl groups from any source
However, these ratings and their discharge rates are very similar, even in real-world scenarios
In short, GLP-1 receptor agonists help the body respond more effectively to meals keeping blood sugar in check, supporting weight management, and lowering long-term risks tied to metabolic conditions